Skip to content

Pfizer PFE Change in Other Assets

Change in Other Assets at other companies

Eli Lilly logo
Eli LillyLLY
$1.65B+98.4%
Amgen logo
AmgenAMGN
-$8M-104%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$7.39M-40.2%
Incyte logo
IncyteINCY
-$9.19M-115%
Exelixis logo
ExelixisEXEL
-$58.65M-189%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$10.47M+1,469%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$137.24B+0.6%
Enterprise value$199.91B+1.7%
P/E11.3×
P/S2.2×0.0×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's change in other assets?
Pfizer (PFE) reported change in other assets of -$322.25M in Q4 2025.
How has Pfizer's change in other assets changed year-over-year?
Pfizer's change in other assets increased by 61.9% year-over-year, from -$845M to -$322.25M.
What is the long-term trend for Pfizer's change in other assets?
Over 4 years (2021 to 2025), Pfizer's change in other assets has grown at a 5.1% compound annual growth rate (CAGR), from $1.06B to -$1.29B.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.